Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hajnalka Jókai
Antidrug Antibody Formation During Tumor Necrosis Factor Α Inhibitor Treatment of Severe Psoriatic Patients in the Real-Life Practice
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
The Role of Predictive Markers in TNF-α Inhibitor Treatment of Psoriasis
Bőrgyógyászati és Venerológiai Szemle
Related publications
Value of Antidrug Antibody Screening in Moderate-To-Severe Rheumatiod Arthritis Patients Who Failed Initial Tumor Necrosis Factor-Alpha Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Infliximab (Anti–Tumor Necrosis Factor Α Antibody)
Archives of Dermatology
Effect of the Biological Drug Etanercept on Tumor Necrosis Factor-Α Levels in Psoriatic Patients
Iraqi Journal of Science
Genetics
Molecular Biology
Geology
Biochemistry
Computer Science
Biotechnology
Chemistry
Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis
Reumatologia
Rheumatology
Allergy
Immunology
Recognition of Human Tumor Necrosis Factor Α (TNF-α) by Therapeutic Antibody Fragment
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis
Therapeutics and Clinical Risk Management
Vasculoprotective Effects of Anti-Tumor Necrosis Factor-Α Treatment in Aging
American Journal of Pathology
Forensic Medicine
Pathology
Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis
Journal of Managed Care Pharmacy
Erratum To: Anti-Tumor Necrosis Factor-Α Therapy and Changes of Flow-Mediated Vasodilatation in Psoriatic and Rheumatoid Arthritis Patients
Internal and Emergency Medicine
Internal Medicine
Emergency Medicine